Showing results (261-270 of 289) with videos related to

Sort By:
Pageof 29
Gynecologic Oncology Research and Practice|May 28, 2016
Characteristics and outcomes for patients with advanced vaginal or vulvar cancer referred to a phase I clinical trials program: the MD Anderson cancer center experienceSiqing Fu, Naiyi Shi, Jennifer Wheler, et al.
BMJ Open|July 5, 2024
Protocol for a systematic review with prospective individual patient data meta-analysis in EGFR-mutant NSCLC with brain metastases to assess the effect of SRS+osimertinib compared to osimertinib alone: the STARLET CollaborationKristy P Robledo, Shilo Lefresne, Yu Yang Soon, et al.
The Lancet. Oncology|July 20, 2010
Quality of life after total laparoscopic hysterectomy versus total abdominal hysterectomy for stage I endometrial cancer (LACE): a randomised trialMonika Janda, Val Gebski, Alison Brand, et al.
Nature Medicine|October 20, 2025
Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trialJeanne Tie, Yuxuan Wang, Jonathan M Loree, et al.
Nature Communications|October 14, 2015
Isotopic ordering in eggshells reflects body temperatures and suggests differing thermophysiology in two Cretaceous dinosaursRobert A Eagle, Marcus Enriquez, Gerald Grellet-Tinner, et al.
Gynecologic Oncology|February 22, 2021
Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committeeJean-Emmanuel Kurtz, Val Gebski, Vladyslav Sukhin, et al.
Oncogene|June 21, 2026
HSP47 is a potential dual cell target and prognostic factor in pancreatic cancerGeorge Sharbeen, Estrella Gonzales-Aloy, Janet Youkhana, et al.
Oncotarget|June 14, 2019
Adaptive responses in a PARP inhibitor window of opportunity trial illustrate limited functional interlesional heterogeneity and potential combination therapy optionsMarilyne Labrie, Tae-Beom Kim, Zhenlin Ju, et al.
European Journal of Cancer (Oxford, England : 1990)|February 12, 2025
Disease-free survival as surrogate for overall survival in esophageal cancer: An individual patient data meta-analysis of neoadjuvant chemotherapy and chemoradiotherapyNicolas Cabrit, Maurice Cheugoua-Zanetsie, Jayne Tierney, et al.
The Lancet. Oncology|August 30, 2024
Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroupCarien L Creutzberg, Jae-Weon Kim, Gemma Eminowicz, et al.
Pageof 29